Mphasis Allots Over 11,000 Equity Shares Following Exercise of Employee Stock Options and Restricted Stock Units
Mphasis Ltd has approved the allotment of a total of 11,867 equity shares against the exercise of both Employee Stock Options (ESOPs) and Restricted Stock Units (RSUs). The decision was made by the ESOP Compensation Committee on June 13, 2026, concerning the Employee Stock Options Plan 2016 and the Restricted Stock Units Plan 2021.The allotment breakdown is detailed as follows:
| Plan | Equity Shares Allotted |
|---|---|
| ESOP 2016 | 10,678 |
| RSU Plan 2021 | 1,189 |
The terms and timeframe for the exercise of these stock options and units are aligned with their respective plan documents. The mechanisms for both plans involve a cashless scheme designed to manage associated financial requirements.
For employees who exercised ESOPs under the Cashless Scheme, Mphasis Employees Equity Reward Trust is responsible for deducting an appropriate number of shares from those allotted under this plan. This deduction covers the exercise price and applicable taxes. Proceeds generated from the sale of these deducted shares will be used by the Trust to repay loans advanced by the Company, along with any applicable taxes.
Similarly, regarding the RSU Plan 2021, Mphasis Employees Benefit Trust will deduct a specific number of shares from those allotted upon the vesting or exercise of RSUs. This deduction covers both the exercise price and relevant taxes. The proceeds from the sale of these deducted shares will be utilized by the Trust to repay company loans and cover applicable taxes.
MPHASIS Stock Price Movement
MphasiS Limited shares slipped by 0.04% on Friday, concluding the session at ₹2270.4 after trading down ₹0.80 from the previous close. The stock saw movement within a range of ₹2255.2 to ₹2302.3 and registered a traded volume of 179,663 shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.